Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.45    -0.65 (-3.23%)
Bid:
19.00
Ask:
19.90
Spread: 0.90 (4.737%)
Market Cap: €111.86b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

BBVA Dividend option

11 Apr 2012 18:22

RNS Number : 1696B
Banco Bilbao Vizcaya Argentaria SA
11 April 2012
 

 

 

Banco Bilbao Vizcaya Argentaria, S.A.(BBVA), in compliance with the Securities Market legislation, hereby communicates the following:

 

 

 

RELEVANT EVENT

In connection with the relevant event of March 28, 2012 (Filing No. 160866), BBVA hereby submits, for purposes of articles 26.1.e) and 41.1.d) of Royal Decree 1310/2005 of November 4, this supplementary document to the Information Document relating to the free-of-charge capital increase by which a system of flexible shareholder remuneration called "Dividend Option" is to be instrumented.

 

Madrid, April 11, 2012

 

supplementary document to the Information Document

 

CAPITAL INCREASE CHARGED TO VOLUNTARY RESERVES

 

BANCO BILBAO VIZCAYA ARGENTARIA, S.A.

 

 

April 11, 2012

 

  

THIS DOCUMENT HAS BEEN PREPARED IN ACCORDANCE WITH ARTICLES 26.1.E) AND 41.1.D) OF ROYAL DECREE 1310/2005 OF NOVEMBER 4.

 

Disclaimer: The English version is a free translation of the original in Spanish for information purposes only. In the event of discrepancy, the Spanish original will prevail

1. INTRODUCTION

This document (the "Supplementary Document") has been issued to supplement the information provided in the information document relating to the capital increase charged to voluntary reserves approved by the ordinary general shareholders' meeting of Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA" or the "Bank") held on March 16, 2012, under item 4.1 of the fourth point of its agenda (the "Capital Increase"), which was published by means of a relevant event on March 28, 2012, with filing number 160866 (the "Information Document"). Capitalized terms used but not defined herein have the meanings assigned to them in the Information Document.

This Supplementary Document sets forth below the information relating to the Capital Increase which was outstanding at the date of publication of the Information Document and, in particular, the number of shares to be issued (with the possibility of incomplete subscription being expressly provided for), the number of free allotment rights necessary to receive one new share ("NAR") and the price at which BBVA has undertaken to acquire free allotment rights from shareholders, in the terms set forth in the Information Document.

This Supplementary Document and the Information Document have been issued in accordance with articles 26.1.e) and 41.1.d) of Royal Decree 1310/2005, of November 4, which provide that the preparation and publication of a prospectus related to the issuance and admission to listing of the shares issued as a consequence of the execution of the Capital Increase will not be necessary "provided that a document is made available containing information on the number and nature of the shares and the reasons for and details of the offer". This Supplementary Document together with the Information Document constitute such document. This Supplementary Document and the Information Document are available on the CNMV's website (www.cnmv.es) and the Bank's website (www.bbva.com).

2. SUPPLEMENTARY INFORMATION TO THE INFORMATION DOCUMENT

The Executive Committee of BBVA, in its meeting held on April 11, 2012, has agreed to implement the Capital Increase in accordance with the terms approved by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012. In accordance with the formulas approved by these bodies, the Executive Committee has approved the following parameters concerning the Capital Increase:

(i) The number of new shares to be issued as a consequence of the execution of the Capital Increase ("New Shares") will be 107,682,603 New Shares. Accordingly, the aggregate nominal value of the Capital Increase will be €52,764,475.47, which is the product of multiplying the number of New Shares 107,682,603 by the nominal value of €0.49 per New Share.

The number of New Shares to be issued is the result of applying the formulas provided for in the applicable resolution adopted by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012, considering that the number of old shares outstanding is 5,061,082,3781 ("NOS"), that the reference market value is €615,000,000 ("RMV") and that the reference price is €5.677 ("reference price" or "RP").2 On this basis:

(a) The number of rights to be assigned ("rights to be assigned" or "NAR") is 47, in accordance with the formula in the shareholders' and board's resolutions (rounded up to the nearest whole number):

NAR = RP x NOS / RMV

which, as applied, results in:

NAR = €5.677 x 5,061,082,378 / 615,000,000 = 47

(b) The number of New Shares to be issued is 107,682,603 New Shares, in accordance with the formula in the shareholders' and board's resolutions (rounded down to the nearest whole number):

New Shares = NOS / NAR

which, as applied, results in:

New Shares = 5,061,082,378 / 47 = 107,682,603

Notwithstanding this, the number of New Shares actually issued and, as a result, the nominal value of the Capital Increase may be less than the foregoing depending on the number of rights acquired by the Bank pursuant to its undertaking to acquire the free allotment rights for a fixed price. BBVA will waive the free allotment rights acquired pursuant to such undertaking. As a result, only those shares corresponding to the free allotment rights which have not been acquired by BBVA pursuant to its undertaking will be issued.

The New Shares will be issued at their nominal value of forty-nine euro cents (€0.49) per New Share, without issuance premium.

1 This amount reflects the voluntary conversion into shares, at the option of the holders, of BBVA’s mandatory convertible subordinated bonds issued in December 2011, after which the number of old shares outstanding is 5,061,082,378.
2 The Reference Price corresponds to the arithmetic mean of the weighted average prices of BBVA’s shares on the Spanish Stock Exchanges (Mercado Continuo) over the five trading sessions immediately prior to April 11, 2012, the date that BBVA’s Executive Committee resolved to effect the Capital Increase, rounded to the nearest thousandth of a euro and, in the case of a half of a thousandth of a euro, the immediately higher thousandth of a euro. 

(ii) The number of rights necessary to receive one New Share is 47.

BBVA shareholders who appear as such in the book-entry registries of Sociedad de Gestión de los Sistemas de Registro, Compensación y Liquidación de Valores, S.A. ("Iberclear") at 23:59 Madrid time on the day of publication of the announcement of the Capital Increase in the Official Bulletin of the Commercial Registry ("Boletín Oficial del Registro Mercantil") (envisaged for April 13, 2012) will receive a free allotment right for each BBVA share held. Consequently, such shareholders will have a right to receive one New Share for each 47 shares held by them on such date.

To ensure that all free allotment rights are effectively exercisable and that the number of New Shares to be issued is a whole number, BBVA has renounced 37 rights corresponding to 37 shares held as treasury shares.

(iii) The fixed purchase price of each freely allotted right assumed by BBVA is €0.118 per right, in accordance with the formula approved by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012 (rounded to the nearest thousandth of a euro and, in the case of a half of a thousandth of a euro, the immediately higher thousandth of a euro):

Purchase price = RP / (NAR +1)

which, as applied, results in:

Purchase price = 5.677 / (47 + 1) = €0.118

Accordingly, shareholders who wish to receive a dividend in cash can sell their rights to BBVA at a gross fixed price of €0.118 per right.

As indicated in the Information Document, this option is granted exclusively to the shareholders of BBVA who have such condition at the time the free allotment rights are allocated and only in connection with the free allotment rights which are originally allocated to them at such time; accordingly, this option will not be available in respect of any free allotment right acquired through a market purchase.

BBVA's undertaking to acquire rights at this fixed price will be in effect from the first trading day of the rights, which is expected to take place on April 16, 2012 through April 25, 2012, both inclusive.3

3 The options, terms and procedures indicated in this information document may not be the same in respect of BBVA shares listed outside Spain, including in the form of BBVA ADSs.

* * *

Banco Bilbao Vizcaya Argentaria, S.A.

P.p.

Erik Schotkamp

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIBMRTMBBBBTT
Date   Source Headline
1st Jun 202610:20 amRNSPeriodic Report on the Buyback Program 01/06/2026
26th May 20267:00 amRNSPeriodic Report on the Buyback Program 25/05/2026
18th May 202610:18 amRNSPeriodic Report on the Buyback Program 18/05/2026
12th May 20266:23 pmRNSHR - Fitch rating upgrade
11th May 202610:17 amRNSPeriodic Report on the Buyback Program 11/05/2026
1st May 20267:00 amRNSIssue of preferred sec. contingently convertible
1st May 20267:00 amRNSChanges in BBVA’s Board of Directors
30th Apr 20268:39 amRNSShare Buyback Program
30th Apr 20267:19 amRNS1Q26 Earnings Presentation
30th Apr 20267:16 amRNS1Q26 Quarterly Report
30th Apr 20267:12 amRNSResults Press Release BBVA 1T2026
22nd Apr 20261:24 pmRNS1T26 Earnings Presentation Announcement
20th Apr 20267:00 amRNSCompletion of the execution of the Second Tranche
17th Apr 20267:14 amRNSEarly redemption of public sector covered bonds
15th Apr 20262:57 pmRNSBBVA Notice to amend final terms GMTN 29
14th Apr 20265:20 pmRNSMREL requirement
13th Apr 202610:19 amRNSPeriodic Report on the Buyback Program 13/04/2026
7th Apr 20267:00 amRNSPeriodic Report on the Buyback Program 06/04/2026
31st Mar 20265:50 pmRNSBBVAs share capital reduction
23rd Mar 20267:00 amRNSPilar 3 Report 2025
20th Mar 202611:50 amRNSShare Buyback Program
6th Mar 20266:19 pmRNSCompletion of the execution of the First Tranche
2nd Mar 202610:18 amRNSPeriodic Report on the Buyback Program 2026/03/02
23rd Feb 202610:29 amRNSPeriodic Report on the Buyback Program 23/02/2026
19th Feb 202610:46 amRNS2025_Individual_Annual_Accounts_and_Management_Rep
19th Feb 202610:37 amRNS2025_Cons_Annual_Accounts_and_Management_Report
16th Feb 202610:24 amRNSPeriodic Report on the Buyback Program 2026/02/16
13th Feb 20265:22 pmRNSApril dividend calendar
13th Feb 20263:33 pmRNS2026 AGM Notice and Proposed Resolutions
11th Feb 20265:44 pmRNSEarly redemption of Senior Preferred Notes
10th Feb 20267:00 amRNS2026 Annual General Meeting Call
9th Feb 202610:11 amRNSPeriodic Report on the Buyback Program 2026/02/09
5th Feb 20267:00 amRNS4Q25 Earnings Report
5th Feb 20267:00 amRNSShareholder remuneration for 2025
5th Feb 20267:00 amRNS4Q25 Earnings Presentation
5th Feb 20267:00 amRNS4Q25 Earnings Press Release
2nd Feb 202610:27 amRNSPeriodic Report on the Buyback Program 02/02/2026
28th Jan 20261:29 pmRNS4Q25 Earnings Presentation Announcement
27th Jan 20267:00 amRNSNew Periodic Report Buyback Program 26/01/2026
26th Jan 202610:30 amRNSPeriodic Report on the Buyback Program 26/01/2026
19th Jan 202610:06 amRNSPeriodic Report on the Buyback Program 19/01/2026
12th Jan 202610:18 amRNSPeriodic Report on the Buyback Program 12/01/2026
2nd Jan 202610:39 amRNSPeriodic Report on the Buyback Program 02/01/2026
23rd Dec 20255:28 pmRNSBBVA's share capital reduction
23rd Dec 20255:28 pmRNSBBVA's share capital reduction
19th Dec 20257:21 amRNSShare Buyback Program
19th Dec 20257:21 amRNSShare Buyback Program
17th Dec 20257:47 amRNSEarly redemption of the entire issuance
11th Dec 20257:00 amRNSCompletion of the execution of the Buyback Program
9th Dec 202510:30 amRNSPeriodic Report on the Buyback Program 2025/12/09

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.